Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis

To assess the kinetics of the humoral and cell-mediated responses after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in rheumatoid arthritis (RA) patients treated with different immunosuppressive therapies. Following vaccine completed schedule, health care workers (HCWs,...

Full description

Saved in:

Bibliographic Details
Published in:	Frontiers in immunology Vol. 13; p. 846753
Main Authors:	Farroni, Chiara, Picchianti-Diamanti, Andrea, Aiello, Alessandra, Nicastri, Emanuele, Laganà, Bruno, Agrati, Chiara, Castilletti, Concetta, Meschi, Silvia, Colavita, Francesca, Cuzzi, Gilda, Casetti, Rita, Grassi, Germana, Petrone, Linda, Vanini, Valentina, Salmi, Andrea, Repele, Federica, Altera, Anna Maria Gerarda, Maffongelli, Gaetano, Corpolongo, Angela, Salemi, Simonetta, Di Rosa, Roberta, Nalli, Gabriele, Sesti, Giorgio, Vaia, Francesco, Puro, Vincenzo, Goletti, Delia
Format:	Journal Article
Language:	English
Published:	Switzerland Frontiers Media S.A 28.02.2022
Subjects:	Abatacept Antibodies, Viral antibody response Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - drug therapy BNT162 Vaccine COVID-19 COVID-19 - prevention & control COVID-19 Vaccines Humans Immunity Immunoglobulin G Immunology Kinetics mRNA vaccine rheumatoid arthritis RNA, Messenger SARS-CoV-2 T-cell response T-Lymphocytes Vaccination whole blood COVID-19 DMARD (disease-modifying antirheumatic drug) antibody response biological therapy whole blood rheumatoid arthritis T-cell response mRNA vaccine
ISSN:	1664-3224, 1664-3224
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!